Advanced Micro Devices (AMD)
Verdict history · AMD
Every call Verdix has made on AMD.
While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.
Click any date below to read that write-up
Three months ago, with the stock at $514 and a BALANCED verdict, the panel saw a growth story that was fully priced with no margin of safety. The subsequent 8% selloff to $473 changed the arithmetic for three of the six voices: the growth story strengthened (data-center revenue doubled, CEO guided 80% H2 server growth), while the price weakened just enough to shift The GARP Operator, The Disruptive-Innovation Seeker, and The Scuttlebutt Growth Investor into bullish territory. The two price-conscious holdouts acknowledge the stronger business but still see the valuation as stretched; they want a deeper pullback before committing.
See methodology for how verdicts are produced. Full track record →
Why the panel isn’t ready to call AMD yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Semiconductors · 2026-06-06 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Six investing legends split on AMD: a genuinely accelerating AI-chip business versus a price that demands flawless execution. Here's the debate and the key levels.Level to watch
Key support 451−3.3% from 466.38
The panel's take
Verdict: WAIT · Conviction: MEDIUM · Last price: USD 466.38 (as of 2026-06-06)
The panel is divided in signal but unusually aligned in substance: almost every framework agrees AMD is a high-quality, fast-accelerating business — and that at roughly 60–70x forward earnings the stock already prices in years of perfect execution. Bulls and bears alike point to the same single fact, valuation, and reach opposite conclusions, which is why the synthesized read lands on WAIT rather than a directional call.
Key levels
Key levels · AMD
USD · as of 2026-06-06Analyst consensus target 478 USD · range 250–665
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance sits at the recent all-time high near USD 546, with a supply zone around 520–530; key support runs from the 5-week moving-average area near 451 down through a historical accumulation zone around 415–437, and the analyst consensus target spans roughly USD 250 to 665 with an average near USD 478.
What legendary investors think
We ran Advanced Micro Devices past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Disruptive-Innovation SeekerGrowth🟢 BullishHigh
The AI accelerator TAM is heading toward $500B+, and AMD's MI400/Helios roadmap plus Meta's up-to-6GW commitment position it to grow from ~6% GPU share into a far larger market; at a PEG near 1.26 the growth isn't fully priced.
The Macro OpportunistMacro🟢 BullishMedium
$725B of 2026 hyperscaler capex (+77% YoY) is the real liquidity driving AMD, and revenue is accelerating (38% → guided 46%) — high conviction on the thesis, but a 70x forward multiple and RSI ~75 argue for patience on entry.
The GARP OperatorGrowth (GARP)⚫ NeutralMedium
A "fast grower" with a fortress balance sheet ($12.3B cash vs $3.2B debt) and PEG ~1.26 — respectable, but at full price rather than a margin of safety; the CUDA software moat caps the upside case.
The Intrinsic-Value ModelerValuation⚫ NeutralMedium
A DCF on 40%-tapering growth and margins reaching ~32% yields a fair value around USD 280–320; at USD 466 the market is treating the bull case as the base case, with the ASIC threat under-appreciated.
The Forensic SkepticContrarian🔴 BearishMedium
Forensics flag a 39% GAAP-vs-non-GAAP EPS gap, a balance sheet ~64% intangibles ($41.5B goodwill from Xilinx), and ~33x tangible book; a weighted intrinsic value near USD 190 leaves no margin of safety.
The Moat CompounderValue🔴 BearishMedium
GAAP ROE of 8.68% fails the 15% bar, the AI-GPU moat is contested (NVIDIA ~80% share), and at ~178x trailing / 60x forward earnings there is no margin of safety in a cyclical industry.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The underlying business is genuinely excellent and accelerating: Q1 2026 revenue +38% YoY to $10.3B, data center +57% to $5.8B, record $2.6B quarterly free cash flow.
- The balance sheet is a fortress — debt/equity ~0.06, ~$9B net cash — and management execution under Lisa Su is widely respected.
- Valuation is the central tension: at ~60–70x forward earnings, the price embeds years of flawless execution.
The real debate
- What's priced in: The Disruptive-Innovation Seeker sees a PEG near 1.26 against a $500B+ TAM as room to run, while the Intrinsic-Value Modeler's DCF says the same price already requires the bull case to become the base case (fair value ~USD 280–320).
- The moat: The Moat Compounder and Forensic Skeptic see a contested position (NVIDIA's CUDA ecosystem, ~80% GPU share) with no asset floor — ~33x tangible book — whereas the Disruptive-Innovation Seeker and Macro Opportunist see AMD as the credible #2 in a market where the #1 can't supply all demand.
- Timing vs. value: The Macro Opportunist is high-conviction on the thesis but wants a pullback to the 415–437 zone for a better setup, while the Forensic Skeptic and Intrinsic-Value Modeler argue the gap to intrinsic value is structural, not a timing question.
The question it comes down to: Is AMD's accelerating AI franchise durable enough to grow into a ~60–70x forward multiple — or does a business at ~6% GPU share and ~8.7% GAAP ROE, priced for perfection, leave too little room for any stumble?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 466.38 / ~760B |
| P/E (TTM / fwd) | ~178x / ~60–70x |
| ROE | 8.68% |
| Operating margin | ~11% GAAP (~25% non-GAAP) |
| Dividend yield | 0% (no dividend) |
| Debt / equity | 0.06 |
| Free cash flow | USD 2.6B (Q1 2026, record); 5.52B (FY2025) |
Figures as of Q1 2026 / June 2026; sourced from AMD IR/SEC filings, GuruFocus, StockAnalysis, and FinanceCharts.
The bottom line
The tension is unusually clean: AMD is one of the best-executing, fastest-growing large-cap semiconductor businesses, with a fortress balance sheet and management whose customers (OpenAI, Meta) are reportedly forecasting demand above the company's own 2027 plan — yet the stock trades at roughly 60–70x forward earnings, near 33x tangible book, with most fair-value estimates clustering well below the current price. What would tip it bullish is durable evidence that ROCm is closing the CUDA gap and that GPU share is crossing into double digits, validating the growth multiple; what would tip it bearish is any deceleration, margin plateau, or hyperscaler shift toward custom silicon that exposes how little room the valuation leaves for error. The recent ~10% pullback from the USD 546 high was largely sector contagion from Broadcom's soft guidance rather than an AMD-specific crack — leaving the core question, growth versus price, unresolved.
contact@verdixhq.com · Published 2026-06-06 · Prices as of 2026-06-06 · Time horizon: 3–12 months · Founder holds a direct position in AMD · AMD verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call AMD yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Semiconductors (AI Accelerators / CPUs) · 2026-06-29 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Six investing legends on AMD after a parabolic 4-5x run: a genuine #2 AI accelerator with landmark OpenAI, Meta and Oracle deals, now priced at ~111x forward earnings — above where even Wall Street's own targets sit. The debate and the key levels.Level to watch
Key resistance 600+3.5% from 579.68
The panel's take
Verdict: WAIT · Conviction: MEDIUM · Last price: USD 579.68 (as of 2026-06-29)
Almost the whole panel likes the business and balks at the price after a parabolic run. AMD has become a credible #2 in AI accelerators: data-center revenue hit a record $5.8B (+57%), total revenue grew ~38%, and landmark commitments — a 6-gigawatt OpenAI deployment, a reported $60B Meta supply agreement, and 50,000 MI450 GPUs for Oracle — give real revenue visibility into 2027. But the stock has run roughly 4–5x (260% over the past year, +11% in the latest week alone to a fresh high), and that's where the disagreement lives. The growth and momentum frameworks see an early-innings share-gain story against NVIDIA's near-monopoly; five-plus frameworks see a stock at ~111x forward earnings pricing near-flawless execution, with fair-value estimates clustering from the high-$200s to the low-$480s — all below the ~$580 price. Tellingly, even the analyst consensus target now sits below the current price, and the chart is a textbook late-stage parabola. The business isn't in question; the entry is. That synthesizes to WAIT.
Key levels
Key levels · AMD
USD · as of 2026-06-29Analyst consensus target 470 USD · range 320–700
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance starts at the ~$600 round number, then measured-move extensions near $650 and $720. Key support sits at ~$525 (the prior breakout weekly close — the first mean-reversion zone), then ~$450 (a ~38% retracement of the rally), with a deeper historical accumulation zone near $335 (the 200-week trend, far below price). The analyst consensus target spans roughly USD 320 to 700 — and notably averages near USD 470, below the current price, an unusual configuration that means the stock has run through most of Wall Street's own near-term targets.
What legendary investors think
We ran AMD past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Disruptive-Innovation SeekerGrowth🟢 BullishHigh
The most credible challenger to NVIDIA's near-monopoly: data-center GPU revenue forecast to surge ~114% to ~$15B in 2026, with Oracle (50K MI450), an OpenAI multi-billion deployment, and hyperscalers in ROCm production. Even 15–20% share of a $300–400B TAM puts AMD's AI segment at $45–80B — "math traditional valuation can't see."
The GARP OperatorGrowth (GARP)⚫ NeutralMedium
A PEG near 4.9 — "nearly five times my threshold" — means the market has priced years of flawless execution; after a 4–5x run "once everybody knows the story, most of the easy money is already made." The catalyst is real, but semis are cyclical. Wait for a pullback.
The Moat CompounderValue🔴 BearishHigh
ROE of ~8.7% is "well below my 15% threshold," and NVIDIA's CUDA still commands ~85% of the market — "a moat built over two decades does not dissolve because a competitor offers cheaper hardware." Paying a punishing multiple for a cyclical with a contested moat offers "no margin of safety whatsoever."
The Intrinsic-Value ModelerValuation⚫ NeutralMedium
At ~55x trailing the market prices AMD capturing 10–15% AI-GPU share *and* 30%+ growth for four years simultaneously, against NVIDIA's software moat; AMD's ~28% margins vs NVIDIA's ~55% mean less cash per dollar of growth. Fair value ~$460–480 (~20% below); interested at $380–420.
The Forensic SkepticContrarian🔴 BearishHigh
~58x forward prices flawless MI450 execution *and* ROCm closing a 15-year CUDA moat; insiders sold ~$126M with zero buys, and the OpenAI warrant (up to 160M shares, penny-priced) is dilution the Street's per-share estimates ignore. Intrinsic ~$280–320; "no margin of safety at $579."
The Macro OpportunistMacro⚫ NeutralMedium
A +168% move in 90 days then +11% above the all-time high "is late-stage parabolic extension, not an early breakout" — with liquidity neutral, "the macro kindling is already burned, we're in the flame." Protect gains, don't add; a weekly close below $520 is the exit.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The AI-accelerator business is real and accelerating: data-center revenue +57% to a record $5.8B, total revenue +38%, record free cash flow, and a clean balance sheet.
- The hyperscaler commitments (OpenAI 6 GW, Meta, Oracle) are structured deals with deployment timelines, not vaporware — genuine demand visibility into 2027.
- The valuation is extended: ~111x forward earnings after a ~4–5x run, with the analyst consensus target itself now below the price.
- The chart is parabolic and overbought (weekly RSI in the high-70s/low-80s), with low short interest meaning little squeeze fuel left.
The real debate
- Early innings or priced-in? The growth and momentum lenses see an S-curve share-gain story with years to run; the valuation lenses see four years of flawless execution already embedded at ~111x forward.
- Is the moat closing or still wide? The bull cites ROCm design wins and dual-sourcing demand; the Moat Compounder and Forensic Skeptic note CUDA still holds ~85% share and ROCm only targets parity by year-end on AMD's own roadmap.
- What about the warrants? The OpenAI deal anchors demand but grants up to ~10% dilution on deployment milestones — a structure the bears say the Street's EPS math doesn't fully reflect.
The question it comes down to: Is AMD an early-stage AI-accelerator winner whose OpenAI/Meta/Oracle deals justify paying up even after a 4–5x run — or a perennial #2 at ~111x forward earnings, priced for share gains, margin expansion, and warrant-diluted execution all going right at once, with Wall Street's own targets already below the price?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 579.68 / ~940B |
| P/E (TTM / fwd) | ~145–171x (GAAP/TTM) / ~111x (forward non-GAAP) |
| ROE | ~8% (depressed by Xilinx goodwill/intangibles) |
| Operating margin | ~25% (non-GAAP) / ~12% (GAAP) |
| Dividend yield | 0% (no dividend) |
| Debt / equity | ~0.06x (net cash) |
| Free cash flow | ~USD 8.6B (TTM; record ~$2.6B in Q1 2026) |
Figures as of Q1 2026 / June 2026; sourced from AMD IR/SEC filings, StockAnalysis, GuruFocus, MarketBeat. GAAP earnings are weighed down by Xilinx-acquisition intangibles, so non-GAAP figures are shown alongside; on a non-GAAP forward basis the PEG is ~1.3, but that assumes 80–90% EPS growth is sustainable — the crux of the valuation debate. The OpenAI warrant (up to ~160M shares) is a dilution factor not fully reflected in per-share consensus.
The bottom line
AMD is the rare name where nearly every framework respects the company and questions the quote. The bull case is concrete and accelerating: a credible #2 AI accelerator with data-center revenue up 57%, a 6-gigawatt OpenAI deployment, reported Meta and Oracle commitments, EPYC taking server share from Intel, and record free cash flow — a structural challenge to NVIDIA's near-monopoly that, if even partly realized, supports a far larger AI franchise. The caution is equally concrete and, after the run, dominant: at ~111x forward earnings the stock has risen ~4–5x and now trades above the average analyst target, ROE sits near 8% with GAAP operating margins around 12%, CUDA still holds the large majority of the market while ROCm only targets parity, insiders have sold heavily, the OpenAI warrants embed real dilution, and five-plus independent fair-value estimates land between the high-$200s and low-$480s — all beneath the ~$580 price — against a textbook late-stage parabolic chart. What would tip the synthesis bullish is execution that grows into the price — the MI450 ramp delivering on schedule, AI-GPU revenue scaling toward the mid-teens of billions, and margins climbing without the warrant dilution overwhelming per-share gains. What keeps it a wait is that, after a vertical move, the price already assumes most of that goes right, leaving little room for the one-quarter slip that semiconductors so often deliver — and the panel's value voices would rather own a genuinely strong business at the $350–480 zone their analysis points to than chase the parabola here.
contact@verdixhq.com · Published 2026-06-29 · Prices as of 2026-06-29 · Time horizon: 3–12 months · Founder holds a direct position in AMD · AMD verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call AMD yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Semiconductors / AI Accelerators · 2026-07-11 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Six investing legends on AMD after a parabolic ~3x run in three months on real hyperscaler wins — OpenAI's 6GW commitment, Meta's $60B deal, Oracle's MI450 order. The AI thesis is genuine, but at ~$558 the stock trades above the average analyst target and every fair-value estimate on the panel. Real story, run-ahead price. The debate and the key levels.Level to watch
Key resistance 575+3.1% from 557.89
The panel's take
Verdict: WAIT · Conviction: MEDIUM · Last price: USD 557.89 (as of 2026-07-11)
AMD is the panel's clearest "the story is real, the price has run past it" call. The fundamental case is no longer speculative: Q1 2026 revenue grew 38% to $10.25B, Data Center revenue jumped 57% to a record $5.78B, and AMD has landed genuine hyperscaler commitments — OpenAI's 6GW, Meta's ~$60B multi-year MI450 deal, and Oracle's 50,000-GPU order — that establish it as a credible second source to Nvidia rather than an also-ran. The balance sheet is pristine (net cash, record $2.6B Q1 free cash flow). But the stock has tripled in roughly three months to $557.89, and the valuation has sprinted far ahead of even the bullish fundamentals: ~179x trailing and 63x forward earnings on an 8% ROE, with the average analyst target ($518) now sitting below the current price even after a wave of upgrades, and the panel's DCF fair values clustering at $350-420. That is why three lenses are outright bearish on valuation, one is neutral, and even the two bulls — the innovation and macro lenses — explicitly want a pullback before adding. The technical picture is a strong but overextended parabola, stretched far above trend. With the fundamental thesis intact and improving but the price above every fair-value estimate on the panel, the synthesis is WAIT.
Key levels
Key levels · AMD
USD · as of 2026-07-11Analyst consensus target 518 USD · range 250–700
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance sits just overhead at the ~$575 round number near the recent high, then ~$600, with a measured-move extension near ~$650. Key support sits at ~$520 (the rising short-term average), then a ~$429 prior-swing shelf that would be the first real pullback zone, with the major structural floor back near the ~$200 base the entire move launched from. The analyst consensus target spans an enormous USD 250 to 700 — averaging near USD 518, which now sits below the current price even after aggressive hikes (Goldman to $640, Cantor to $700). A below-spot average target after a 3x run is the market's own signal that price has, for now, outrun the Street.
What legendary investors think
We ran AMD past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue🔴 BearishMedium
"Paying 63x forward earnings for an 8% ROE business is speculation on a narrative, not investment in a proven compounder." The balance sheet is clean and Q1 growth is real (revenue +38%, record $2.6B FCF), but ROE still sits well below a 15% bar, and AMD "hasn't built the same switching-cost fortress" as Nvidia's ecosystem. Wants durable 15%+ ROE or a price cut by half before there's any margin of safety.
The GARP OperatorGrowth (GARP)⚫ NeutralMedium
"35% forecast EPS growth is exactly the kind of number that gets my attention" — but a PEG near ~1.8 (63x forward ÷ ~35% growth) is already in the "getting expensive" zone, and a ~180x trailing multiple says "a lot of that growth is already baked in." Wants a pullback toward PEG 1.0-1.3 "before backing up the truck — right now you're paying stalwart-plus prices for fast-grower risk."
The Disruptive-Innovation SeekerGrowth🟢 BullishHigh
AMD is "on the early-adoption S-curve of the AI accelerator platform shift" — the MI400/MI450 Helios rack-scale architecture makes it a credible second source in a Nvidia-dominated market. Data Center hit a record $5.8B (+57%), Q2 guided to ~$11.2B, and the OpenAI 6GW and Meta ~$60B commitments "validate real hyperscaler diversification." ROCm's maturation is the key variable for durable share. Five-year view far higher.
The Intrinsic-Value ModelerValuation🔴 BearishMedium
A DCF (35% growth fading to 15%, operating margin expanding toward 30%, 10% WACC for AI-capex cyclicality and hyperscaler concentration) yields fair value around $350-420 — well below the tape. "At ~19x trailing sales, the market is pricing AMD to sustain Nvidia-like growth *and* margin expansion for years, a narrow band of outcomes." The MI450 wins are real, "but price has run ahead of a plausible base case." Wants $380-420.
The Forensic SkepticContrarian🔴 BearishMedium
"At $558 the stock sits on top of Wall Street's bull-case targets — the market isn't pricing current results, it's pricing flawless 2027 MI400 execution today, eighteen months early." The margin gap is the tell: non-GAAP gross margin ~53-56% versus Nvidia's ~75%. "AMD is winning volume but not margin structure — a share-taker at Nvidia's crumbs, not a margin equal — and at ~40-63x forward the multiple has stopped discounting that gap."
The Macro OpportunistMacro🟢 BullishMedium
"Ride it, but tighten up." AMD is ~16% above its 200-day with the uptrend intact and no technical damage, but "this is a liquidity-driven melt-up, not a value trade," with RSI overbought. Would flip bearish fast on a Fed hike surprise or a hyperscaler capex guide-down. Wants a pullback toward the 200-day or a base "rather than chasing here."
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The AI wins are real and specific: OpenAI 6GW, Meta ~$60B, Oracle 50K MI450 GPUs — genuine second-source validation, with Data Center +57%.
- The balance sheet is excellent: net cash, record $2.6B Q1 free cash flow.
- The valuation is extreme: ~179x trailing / ~63x forward on an 8% ROE, with the average analyst target now below the price.
- Even the bulls want a pullback: the innovation and macro lenses like the thesis but not the entry after a 3x run.
The real debate
- Second source or Nvidia's equal? The innovation lens sees a durable share-gain story; the forensic lens sees a volume winner stuck at ~55% gross margin against Nvidia's ~75%.
- Priced for growth or for perfection? The macro/innovation lenses ride the trend; the value and valuation lenses say the price already discounts flawless 2027 execution.
- How much does ROCm matter? Software maturation is the swing factor for whether AMD keeps share or stays cyclical.
The question it comes down to: AMD has genuinely won a seat at the AI-accelerator table — but at ~$558, above the average analyst target and every fair-value estimate on the panel, is the question whether to own the business or whether to wait for a price that reflects it?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 557.89 / ~906B |
| P/E (TTM / fwd) | ~179x / ~63x (vs ~116x trailing-average) |
| Q1 2026 revenue | USD 10.25B (+38% YoY); Data Center $5.78B (+57%), Client & Gaming $3.6B (+23%) |
| Q2 2026 guide | ~$11.2B (+46% YoY), gross margin ~56% |
| ROE / gross margin | ~8% / ~55% non-GAAP (vs Nvidia ~75%) |
| AI accelerators | OpenAI 6GW · Meta ~$60B/5yr · Oracle 50K MI450; Nvidia still ~80-90% share |
| Balance sheet | Net cash (cash ~$12.3B vs debt ~$3.2B); record Q1 FCF $2.6B; no dividend |
Figures as of Q1 2026 (reported May 5, 2026) / July 11, 2026; sourced from AMD IR/SEC filings, StockAnalysis, GuruFocus, MacroTrends, TheStreet, Techi. The hyperscaler commitments (OpenAI 6GW, Meta ~$60B, Oracle 50K MI450) are real, but AMD remains a second source — Nvidia holds ~80-90% AI-accelerator share and a ~20-point gross-margin lead. Valuation is extreme (~179x trailing / ~63x forward on 8% ROE), and the average analyst target ($518) sits below the price after a 3x, three-month run. Catalysts: "Advancing AI 2026" event July 22-23; Q2 earnings ~Aug 4, 2026.
The bottom line
AMD is the panel's most extended WAIT — a company that has genuinely earned its place in the AI-accelerator race, wrapped in a stock that has already priced years of flawless execution. The bull case is real and concrete: revenue up 38%, Data Center up 57% to a record, a pristine net-cash balance sheet, and marquee commitments from OpenAI, Meta, and Oracle that make AMD a credible second source to Nvidia — which is why the innovation lens holds a high-conviction five-year view. But the panel's caution is equally concrete and, at this price, decisive: after tripling in roughly three months the stock trades at ~179x trailing and ~63x forward earnings on an 8% ROE, above the average analyst target and above every fair-value estimate on the panel ($350-420), while still carrying a ~20-point gross-margin gap to Nvidia. Tellingly, even the two bulls say the same thing as the bears about the entry — wait for a pullback. What would tip the call bullish is either the price digesting back toward the $420-520 zone or the fundamentals catching up — MI450 benchmarks at the July 22-23 event and an Aug 4 print proving durable share and margin expansion. What keeps it a wait is that, right now, buyers are paying a price the Street's own average target no longer supports for a business still fighting Nvidia's moat — the AI seat is won, but the entry is the issue.
contact@verdixhq.com · Published 2026-07-11 · Prices as of 2026-07-11 · Time horizon: 3–12 months · No direct position held in AMD · AMD verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call AMD yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Semiconductors / AI Accelerators · 2026-07-18 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Six investing legends revisit AMD after an 11% weekly reversal from the $574 high to $495.76. The hyperscaler story — OpenAI, Meta, Oracle — is unchanged, but the panel splits on whether the pullback made the ~56x forward multiple cheap enough with two live catalysts still ahead. The debate and the key levels.Level to watch
Key resistance 520+4.9% from 495.76
The panel's take
Verdict: WAIT · Conviction: MEDIUM · Last price: USD 495.76 (as of 2026-07-18)
What changed since 2026-07-11:
- Price: USD 557.89 → 495.76 (-11.1%) — an 11% weekly reversal off the $574 marginal high, closing below the flattening ~$520 trend line.
- Panel: 2 of 6 → 1 of 6 now Bullish (The Macro Opportunist flipped from Bullish to Neutral) — the technical damage from the reversal outweighed fundamentals that didn't move.
- Trigger: the Advancing AI event (July 22-23) and the Q2 print (~Aug 4), both still ahead.
- Verdict: WAIT (unchanged)
AMD's fundamental story hasn't moved this week — the same 8% ROE and hyperscaler commitments, the same Q1 print — only the price did. Five of six lenses read the drop as valuation digestion rather than thesis break: the forward multiple has compressed from ~63x to ~56x on that unchanged ROE, but the panel's DCF and owner-earnings estimates still cluster at $350-420, leaving a 20-40% gap even after the pullback.
Key levels
Key levels · AMD
USD · as of 2026-07-18Analyst consensus target 518 USD · range 250–700
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance sits at the flattened ~$520 average, extending to a $520-525 reclaim zone, with the $574 high marking a historical resistance zone from this week's rejection. Key support begins near ~$460, then a ~$420 shelf that lines up with the panel's DCF-based fair-value range, with ~$350 marking the low end of that same historical accumulation zone. The analyst consensus target spans USD 250 to 700, averaging near USD 518 — a level the stock now trades just below, a reversal from last week when price sat above the average target.
What legendary investors think
We ran AMD past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue / Moat🔴 BearishMedium
"At ~56x forward earnings against an 8% ROE, you're still paying a growth-stock price for a business that hasn't yet proven it can earn like one." Even after the drop, AMD at $495.76 sits 20-40% above the $350-420 owner-earnings estimate — prefers to watch from the sidelines until that gap closes or earnings power catches up, with the Advancing AI event and Q2 print still ahead.
The GARP OperatorGARP⚫ NeutralMedium
The OpenAI 6GW, Meta $60B, and Oracle 50,000-GPU commitments plus 57% Data Center growth are "a real story, not hype," but ~56x forward earnings against an 8% ROE is more than the growth rate justifies under PEG discipline. The rejection at $574 and 11% reversal is "exactly what I want to see" before adding — wants the Advancing AI event and August 4 print to resolve before treating this as more than the first leg toward the $420 shelf.
The Disruptive-Innovation SeekerDisruptive Innovation🟢 BullishMedium
Data Center revenue grew 57% YoY and the OpenAI, Meta, and Oracle commitments confirm AMD as a credible second source to Nvidia — "platform disruption that expands TAM rather than shrinks it." The multiple has already compressed from ~63x to ~56x forward while the growth curve hasn't budged; the five-year view looks through the flattened line at $520 to the Advancing AI event and Q2 print, but wants confirmation the $460 low holds.
The Intrinsic-Value ModelerValuation / DCF🔴 BearishMedium
A DCF built on 35%+ near-term growth and margin expansion still tops out around $350-420, so the post-drop $495.76 remains roughly 20-40% above fair value. The rejection at the previously flagged $574 resistance reads as "the market re-testing conviction, not capitulating on it" — wants the Advancing AI event and August 4 print to move the numbers before treating the pullback as opportunity.
The Forensic SkepticContrarian / Forensic🔴 BearishMedium
An 11% weekly reversal off a marginal high at exactly the $574 level flagged a week earlier "is not noise" — it's the market front-running two unresolved catalysts with zero new fundamental data since the May 5 print. At ~56x forward earnings on an unchanged 8% ROE, the stock is still 30-40% above the $350-420 DCF range, and a close below the flattening $520 line is "a warning, not a green light."
The Macro OpportunistMacro / Timing⚫ NeutralMedium
The 11.1% reversal off $574, closing back below a flattened line near $520, is "exactly the kind of technical damage I reduce into regardless of how good the fundamental story is." Fundamentals are unchanged (same 8% ROE, same Q1 print), only the price moved. Sees $460 as the line for a genuine trend break and a $520-525 reclaim on volume as the signal to size back into the AI compute story; "until then this is a watch, not a bet."
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The hyperscaler story is real and unchanged: OpenAI 6GW, Meta ~$60B, Oracle 50,000 MI450 GPUs, Data Center revenue +57% YoY — no lens disputes the fundamentals.
- Valuation remains the constraint: ~56x forward earnings on an 8% ROE, 20-40% above the panel's $350-420 DCF / owner-earnings range even after the drop.
- Two live catalysts are on deck and every lens wants them to resolve first: the Advancing AI event (July 22-23) and the Q2 print (~Aug 4).
- Even the lone bull sets a condition rather than buying outright: the innovation lens wants the $460 low to hold before treating this as confirmed.
The real debate
- Has the pullback done enough valuation work? The Disruptive-Innovation Seeker reads the multiple compression from ~63x to ~56x as the valuation catching up to the growth curve, while the Moat Compounder, the Intrinsic-Value Modeler, and the Forensic Skeptic still see a 20-40% gap to fair value.
- Healthy reset or warning sign? The Innovation lens treats the flattening line at $520 as noise to look through toward the next catalysts; the Forensic Skeptic and Macro Opportunist read the same close below $520 as technical damage that argues for caution.
- Wait for the catalyst, or use the pullback now? The GARP Operator and Macro Opportunist want the Advancing AI event and Q2 print to resolve before deciding; the Innovation lens is already leaning toward the weakness holding up.
The question it comes down to: with the AI story unchanged and two live catalysts nine and eighteen days out, does the multiple's compression from ~63x to ~56x forward earnings already reflect a fair price for the growth, or does the remaining 20-40% gap to the panel's $350-420 DCF range mean the pullback has further to run toward the $420-460 zone?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 495.76 / n/a |
| P/E (TTM / fwd) | n/a / ~56x |
| ROE | ~8% |
| Operating margin | n/a |
| Dividend yield | 0% (no dividend) |
| Debt / equity | n/a |
| Free cash flow | USD 2.6B (Q1 2026, record) |
Fundamentals as of Q1 2026 (reported May 5, 2026) — no new print has landed since, per the panel's own read that "nothing new happened, only the price did." Price and valuation multiples as of July 18, 2026. Next scheduled catalysts: the Advancing AI event, July 22-23, 2026, and Q2 2026 earnings, ~August 4, 2026.
The bottom line
What would tip the call bullish: the Advancing AI event (July 22-23) delivering concrete MI450 benchmarks, or the August 4 print confirming durable Data Center share and margin expansion. What would tip it bearish: a close that breaks the ~$460 level, which the macro lens flags as the line for a genuine trend break rather than a routine pullback. Barring either, the value-oriented lenses see the price continuing to digest toward the $420-460 zone as the more likely near-term path before the panel reconsiders. The panel reconvenes once both catalysts resolve, whichever direction they push the multiple.
contact@verdixhq.com · Published 2026-07-18 · Prices as of 2026-07-18 · Time horizon: 3–12 months · No direct position held in AMD · AMD verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call AMD yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Semiconductors / AI Accelerators · 2026-07-25 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Six investing lenses reconvene on AMD after the Advancing AI event delivered the exact catalyst last week's panel was waiting on — a new hyperscaler (Anthropic, up to 2GW), an expanded Azure partnership, and a broad wave of analyst target hikes that pushed the panel's bullish count from one of six to three. Price reclaimed the $520-525 zone flagged as the trigger, though on in-line rather than surging volume, and the second conditioning catalyst — the August 4 print — is still ahead. The verdict holds at WAIT while the multiple's re-expansion awaits confirmation in the actual numbers. The debate and the key levels.Level to watch
Key resistance 525+0.6% from 521.95
The panel's take
Verdict: WAIT · Conviction: MEDIUM · Last price: USD 521.95 (as of 2026-07-25)
What changed since 2026-07-18:
- Price: USD 495.76 → 521.95 (+5.28%) — reclaimed the $520-525 zone flagged last week as the trigger, though the week's OHLC shows in-line (~130M) rather than surging (2x+) volume behind the move, so the framework's bar for a confirmed breakout isn't met yet.
- Panel: 1 of 6 → 3 of 6 now Bullish (The GARP Operator and The Macro Opportunist upgraded from Neutral to Bullish; The Forensic Skeptic upgraded from Bearish to Neutral) — The Disruptive-Innovation Seeker stays Bullish. The Moat Compounder and The Intrinsic-Value Modeler remain Bearish, arguing the valuation gap widened rather than closed.
- Catalyst: the Advancing AI event (July 22-23) resolved favorably — MI400/Helios launch, an expanded Microsoft Azure partnership, and a new hyperscaler commitment (Anthropic, up to 2GW of MI450 capacity) alongside a broad analyst price-target-hike wave (Goldman to $640, Citigroup upgraded to Buy at $575, Rosenblatt to $665, Bank of America to $620). The second flagged catalyst — Q2 earnings, ~August 4 — has not landed yet.
- New risk/offset: trailing P/E is now read at ~171x (64% above the 10-year median) per one source, with the forward multiple reported anywhere from ~57x to ~77x depending on source and EPS-estimate vintage — the valuation gap most lenses were watching has, if anything, gotten wider even as sentiment improved.
- Verdict: WAIT (unchanged) — one of two conditioning catalysts resolved bullishly, but the reclaim lacks volume confirmation and the second, more decisive catalyst is still nine days out.
Half of last week's stated conditions have now been met, and met convincingly: the Advancing AI event was substance, not a slide deck, and the market's reaction — a new hyperscaler name, reaffirmed Azure demand, and a coordinated wave of analyst upgrades — is real information landing on the tape, not sentiment alone. But the underlying financials are unchanged since the May 5 Q1 print (still ~8% ROE, still no dividend), the reclaim of $520-525 came on ordinary rather than climactic volume, and the trailing multiple has re-expanded on the same earnings base the bears were already calling rich. With the Q2 print — the one input that can actually move the panel's DCF and ROE assumptions — still ahead on August 4, the synthesis stays WAIT: the setup has visibly improved, but the confirmation the framework requires (volume-backed technical breakout, or an earnings print that narrows the valuation gap) hasn't arrived yet.
Key levels
Key levels · AMD
USD · as of 2026-07-25Analyst consensus target 570 USD · range 320–1,250
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Price is now sitting inside the R2/R1 band (520-525), being tested and partially reclaimed rather than decisively cleared — a strong weekly close above $525 on above-average volume is the condition the technical read still wants before calling this zone resistance-turned-support. The $574 high (R3) held untested this week. On the support side, $460 (S1) was touched and held during the prior week's reversal, keeping the broader multi-quarter uptrend structure technically intact; $420 (S2) and $350 (S3) remain unchanged and untested this cycle. The analyst consensus band widened and shifted up — one tracker puts the average near USD 570.6 (51 analysts) against a USD 320-1,250 spread, versus last week's ~USD 518 average — with price now trading roughly in line with, rather than above, the low end of that revised band.
What legendary investors think
We ran AMD past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue / Moat🔴 BearishMedium
"A roadmap slide is not a cash flow statement — I'll pay for what the business earns, not for what a keynote promises it might." ROE is still ~8%, unchanged since May, while the stock added another ~9% off the Advancing AI event and a Goldman target bump; every dollar added before the Aug 4 print without a corresponding dollar of proven earnings power widens the gap to the $350-420 owner-earnings range, now closer to 35-45%.
The GARP OperatorGARP🟢 BullishMedium
"When the earnings estimates move up as fast as the stock, that's the kind of expensive I can live with." The Advancing AI event brought Microsoft, Meta, and OpenAI names actually attached to commitments, and 35 analyst EPS upgrades with zero revenue downgrades means the growth side of the PEG equation moved too — not just the price side. Still not calling 56-77x cheap; wants the Aug 4 print to confirm the 46% Q2 guide before moving off Medium.
The Disruptive-Innovation SeekerDisruptive Innovation🟢 BullishMedium
"When your own customer becomes your investor — AMD financing Anthropic's adoption with $5B tied to deployment milestones — that's not desperation, that's building the moat with someone else's balance sheet risk shared." Data Center growth at 57% YoY with three hyperscaler-scale commitments now underwriting demand reads as an S-curve inflection arriving on schedule, though the $460 level held untested and remains the line that would break the thesis.
The Intrinsic-Value ModelerValuation / DCF🔴 BearishMedium
"The multiple got more excited, the cash flows didn't get more real." The DCF hasn't moved off $350-420 because nothing has landed in the cash flow statement since May 5; at $521.95 the gap widened to roughly 24-49% overvalued. Analyst targets moving ahead of the Aug 4 numbers is "exactly the kind of second-order signal I distrust."
The Forensic SkepticContrarian / Forensic⚫ NeutralMedium
"A vendor commitment is not an income statement — I want to see the ROE move before I believe the multiple should." Upgraded off Bearish because the technical warning from the prior reversal is now falsified, but not bullish either — the stock re-rated back toward its old ~63x forward multiple on the same unaudited 8% ROE, and flags the Street-high $1,250 target as dispersion that "reads more like analyst herd-chasing than independent re-underwriting."
The Macro OpportunistMacro / Timing🟢 BullishMedium
"The reclaim is real, but it's fresh and it faded fast into a sector-wide wobble — that's not the kind of follow-through I bet big size on." The stated $520-525 reclaim-on-catalyst trigger fired, backed by a genuine, dated hyperscaler commitment (Anthropic) rather than a promise, but a hawkish-leaning Fed backdrop and the pullback into the close keep conviction at Medium rather than higher.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The Advancing AI event delivered real, dated fundamental information — Anthropic's 2GW commitment, the expanded Azure partnership, concrete MI400/Helios/Zen 6 specs — no lens disputes that this landed as substance rather than hype.
- The underlying financials haven't moved: still ~8% ROE, still the same Q1 print, still no dividend — every lens agrees nothing has actually landed in the cash flow statement since May 5.
- The August 4 print is the swing event every lens is waiting on before raising or lowering conviction further; none treats this week's move as fully resolving the setup.
- Even the newly-bullish lenses attach a condition rather than calling this settled — the reclaim needs earnings confirmation, not just a catalyst-driven bounce.
The real debate
- Has the analyst re-rating earned itself, or is it herd-chasing? The GARP Operator reads 35 analyst EPS upgrades as the growth side of the equation genuinely moving, not just the price side; the Forensic Skeptic reads the same wave — especially the Street-high target dispersion — as analysts chasing an event rather than independently re-underwriting the business.
- Commitments vs. proof: the Disruptive-Innovation Seeker and Macro Opportunist treat the Anthropic and Azure commitments as real, bookable demand; the Moat Compounder and Intrinsic-Value Modeler insist a commitment is not an earnings statement and the valuation gap has only widened on the same 8% ROE.
- Confirmed reclaim or fragile bounce? The Macro Opportunist flags the reclaim fading fast into a sector-wide wobble as reason for caution; the Forensic Skeptic moved off Bearish because the technical break-down it feared didn't happen, but stops short of calling the reclaim durable.
The question it comes down to: with one of the two conditioning catalysts (Advancing AI) now resolved bullishly and the second (Q2 earnings, ~Aug 4) still ahead, does the reclaim of the $520-525 zone on genuine hyperscaler commitments already justify the ~57-77x forward multiple, or does the panel need the actual margin and ROE numbers from the August print before treating the multiple's re-expansion as earned rather than borrowed?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 521.95 / ~USD 821B |
| P/E (TTM / fwd) | ~171x / ~57-77x (source-dependent) |
| ROE | ~8% |
| Operating margin | n/a |
| Dividend yield | 0% (no dividend) |
| Debt / equity | n/a |
| Free cash flow | USD 2.6B (Q1 2026, record) |
Fundamentals as of Q1 2026 (reported May 5, 2026) — unchanged pending the Q2 print. Trailing P/E ~171x per GuruFocus (2026-07-25); forward P/E reported at 76.9x per stockanalysis.com versus ~56x in the prior article's read — treat the spread as source/EPS-vintage variance, not yet resolved. Price and OHLC as of the week of 2026-07-24 (a partial-week bar holding the prior week's 2026-07-20 close); market cap ~USD 821B per companiesmarketcap.com (2026-07-21). Next scheduled catalyst: Q2 2026 earnings, ~August 4, 2026.
The bottom line
What would tip the call bullish: a strong weekly close above $525 on 2x-plus volume (confirming the reclaim technically), or the August 4 print showing ROE and Data Center margins actually catching up to the re-expanded multiple. What would tip it bearish: a close back below $460, which the framework still flags as the line for a genuine trend break, or a Q2 print that merely meets estimates without margin proof against a stock already trading near its highs. Barring either, the panel's split — three lenses now bullish on a real, dated catalyst wave, two still bearish on a widening valuation gap, one parked in between — argues for holding at WAIT rather than forcing a directional call nine days ahead of the one print that can actually settle the debate.
contact@verdixhq.com · Published 2026-07-25 · Prices as of 2026-07-25 · Time horizon: 3–12 months · No direct position held in AMD · AMD verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call AMD yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Information Technology · 2026-08-01 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Six investing archetypes break down AMD at $476: they all love the AI growth story and Lisa Su's execution but split sharply on whether the 150x trailing P/E leaves any margin of safety. The panel lands on WAIT — the price is the sole blocker, with a pullback to $418–$436 or a weekly close above $482 as the two triggers that could flip the call.Level to watch
Key resistance 481.95+1.2% from 476.15
The panel's take
Verdict: WAIT · Conviction: MED · Last price: USD 476.15
What changed since 2026-07-25:
- Price: 521.95 → 476.15 (-8.77%)
- Panel: 3 of 6 → 1 of 6 now Bullish — composition also changed: added The Quality Rationalist, The Scuttlebutt Growth Investor; removed The Macro Opportunist, The Moat Compounder
- Trigger: Upside watch: a weekly close above $481.95 with expanding volume, or a pullback to the $418–$436 support zone with a confirmed weekly MACD bullish turn. Downside watch: a weekly close below $436.58 (EMA20 breakdown), or a Q2 FY2026 earnings miss with guidance cut that fractures the AI growth narrative and triggers multiple compression.
- Verdict: WAIT (unchanged)
Since the July 25 verdict, AMD has dropped 8.8% from $521.95 to $476.15 — moving closer to the support zone the GARP Operator and Scuttlebutt Growth Investor flagged as the level where the valuation case improves. Yet the panel's verdict remains WAIT because the decline hasn't been deep enough to satisfy the Quality Rationalist's $350–400 threshold or the Intrinsic-Value Modeler's structural objection to any price above $115–$190. Crucially, the prior panel's Moat Compounder and Macro Opportunist have been replaced by the more cautious Quality Rationalist and Scuttlebutt Growth Investor, shifting the panel's center of gravity further toward patience — while the Disruptive-Innovation Seeker remains the lone bull, unchanged in conviction that the S-curve will overwhelm short-term price noise.
The split is bullish conviction vs. cautious patience at its core: The Disruptive-Innovation Seeker is Bullish, while the four cautious voices all like the business — even the most bearish (The Intrinsic-Value Modeler, The Forensic Skeptic) concede AMD is a well-run company with real AI tailwinds — but reject the current price. The business-quality debate (narrow vs. widening moat) creates genuine uncertainty, but the dominant blocker is price: the technical-scout and The GARP Operator explicitly want a pullback to $436 or a breakout above $482, and The Quality Rationalist wants a 20-30% decline before its framework treats the stock as attractively priced. The Intrinsic-Value Modeler and The Forensic Skeptic's intrinsic values ($115–$190) render the stock uninvestable to them, making their objection structural, but even they frame it as "good company, terrible price" rather than a broken business. The verdict is WAIT (not HOLD) because price is the single blocker AND there is an identifiable trigger: either a pullback to $418–$436 support or a weekly close above $482.
Key levels
Key levels · AMD
USD · as of 2026-08-01Key support & resistance — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance sits at USD 481.95 (R1) up to USD 584.73 (R3), with key support at USD 436.58 (S1) down to USD 331.70 (S3); an analyst consensus target was not available in this data pull.
What legendary investors think
We ran Advanced Micro Devices past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Intrinsic-Value ModelerValuation/DCF🔴 BearishMed
Signal: A DCF built on 30% revenue growth for three years and a 30% GAAP operating margin target still yields only ~$115/share — a 76% downside from the current $476 price, because the market has already discounted the flawless-victory scenario. Conviction: Conviction is elevated because four independent valuation methods converge on massive overvaluation, the beta of 2.47 demands a 14% WACC that the market is ignoring, and even the most generous bull case (40% margins, lower discount rate) cannot reach the current price.
The GARP OperatorGrowth (GARP)⚫ NeutralMed
Signal: The forward PEG of 0.37 looks cheap, but a pullback to the 20-week EMA near $436 would meaningfully improve the valuation case — and the monthly RSI at 74 with a fresh weekly MACD bearish cross says that pullback is more likely than not. Conviction: Conviction is held back because the growth story is real and the balance sheet is pristine, but the trailing P/E of 150x and the technical exhaustion signals create a timing problem that patience can solve.
The Scuttlebutt Growth InvestorGrowth/Management⚫ NeutralMed
Signal: AMD passes 14 of 15 Fisher checklist points with elite management and a 57% data-center growth rate, but the stock is priced for perfection at 150x trailing earnings, and the weekly MACD bearish cross favors waiting for a pullback to the EMA20 at ~$436 or a confirmed breakout above $482. Conviction: Conviction is constrained by a single unresolved tension: the business quality is near-perfect by Fisher's framework, yet the current price embeds assumptions that leave zero room for even a minor execution stumble.
The Disruptive-Innovation SeekerDisruptive Innovation🟢 BullishMed
Signal: AMD sits on the biggest technology S-curve of the decade with a $400B+ five-year TAM, and the forward PEG of 0.36x reveals the stock is cheap when you look through backward-looking P/E ratios to the 30%+ compounding trajectory ahead. Conviction: High conviction rests on multiple reinforcing signals: Wright's Law cost declines from chiplet architecture, hyperscaler multi-vendor urgency, a pristine balance sheet self-funding R&D, and a CEO whose execution record is proven across multiple product cycles.
The Forensic SkepticContrarian/Forensic🔴 BearishMed
Signal: The trailing P/E of 150x and EV/EBITDA of 107x leave zero margin of safety, and a weighted intrinsic-value estimate of ~$190 implies roughly 60% downside — the PEG ratio is a trap because it depends on growth rates that are already decelerating. Conviction: Conviction is high because the overvaluation signal is corroborated by technical exhaustion (monthly RSI 74, weekly MACD bearish cross), a narrow and contested moat rating, and dangerously bullish analyst consensus — 41 of 51 at Buy with only 21% average upside.
The Quality RationalistMental Models/Quality⚫ NeutralMed
Signal: AMD is a good business but not a wonderful one — its moat is narrow, the ROE is only 8%, and I need a 20-30% pullback to the $350-400 range before the forward P/E of ~20-25x would make the quality-adjusted price worth considering. Conviction: Conviction is held back because the AI narrative is a powerful social-proof machine pricing in near-perfect execution, while the semiconductor industry's brutal cyclicality means the moat remains unproven in a downturn.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All six archetypes agree AMD is a well-run company with real AI tailwinds, a pristine balance sheet, and strong execution under Lisa Su.
- Every archetype acknowledges that data-center growth is genuine — 57% YoY data-center revenue growth is not disputed.
- Even the bears (Intrinsic-Value Modeler, Forensic Skeptic) concede the business is good — their objection is purely about price, not fraud or structural decay.
- Five of six agree that a pullback would strengthen the valuation case; the only dissenter is the Disruptive-Innovation Seeker, who argues that waiting for a dip risks missing the S-curve entirely.
- All agree Q2 FY2026 earnings on August 4 represent the next major catalyst — a beat or miss there reshapes the entire debate.
The real debate
- The Disruptive-Innovation Seeker sees the forward PEG of 0.36x as evidence the stock is cheap, while the Forensic Skeptic calls the PEG ratio a trap because the 90% EPS growth it relies on is unsustainable — two archetypes looking at the same number and drawing opposite conclusions.
- The Intrinsic-Value Modeler and Forensic Skeptic both produce intrinsic value estimates ($115 and $190) that render the stock uninvestable at any entry above those levels, while the GARP Operator and Scuttlebutt Growth Investor would happily buy on a pullback to $418–$436 — the debate is whether AMD is structurally overvalued or merely temporarily overpriced.
- The Quality Rationalist wants proof the moat widens before paying any premium, whereas the Scuttlebutt Growth Investor already scores the moat at 14/15 on the Fisher checklist — the same evidence yields 'narrow and unproven' versus 'near-perfect and durable.'
- The Disruptive-Innovation Seeker treats the monthly Stage 2 trend as the only signal that matters for a 5-year horizon, while three other archetypes see the monthly RSI at 74 and weekly MACD bearish cross as actionable warnings that demand patience now.
The question it comes down to: Is AMD's AI growth trajectory durable enough to grow into a $476 price before the multiple compresses, or does the valuation already discount a future so perfect that even strong execution won't save investors from a re-rating?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 476.15 / n/a |
| P/E (TTM / fwd) | 150.1x–166.49x / 32.9x |
| ROE | 8.06% |
| Operating margin | 14.4% |
| Dividend yield | n/a |
| Debt / equity | 0.06x |
| Free cash flow | USD 6.74B (FY2025) |
Figures as of 2026-08-01; sourced from alcapitaladvisory.com, seekreturns.com, and clearthesis.ai (fundamental_scout).
The bottom line
The single number to watch is the weekly close relative to $436.58 — the 20-week EMA. A breakdown below that level with volume would shift the technical consensus from "pullback likely" to "trend damaged," potentially accelerating selling toward the $350–400 range where the Quality Rationalist and Forensic Skeptic might reassess. On the upside, a weekly close above $481.95 — the 23.6% Fibonacci retracement from the prior cycle — with expanding volume would break the bearish MACD cross and likely force the GARP Operator and Scuttlebutt Growth Investor off the sidelines. Q2 FY2026 earnings on August 4 are the make-or-break catalyst: consensus expects ~46% YoY revenue growth and 56% non-GAAP gross margins; a meaningful miss on either metric would fracture the AI growth narrative that even the cautious voices are pricing in at current levels. Between now and then, the $418–$436 zone is the historical accumulation area where prior pullbacks found buyers, and any test of that zone with a confirmed weekly MACD bullish turn would tilt the balance toward the bull case.
contact@verdixhq.com · Published 2026-08-01 · Prices as of 2026-08-01 · Time horizon: 3–12 months · Founder holds a direct position in AMD · AMD verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call AMD yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Information Technology · 2026-08-08 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitHIGH confidence
Why
Five archetypal investors debate AMD at $483 after a beat-and-raise quarter that somehow sent the stock down 9%. Two bulls argue the AI inference S-curve and exceptional management justify holding through any near-term noise, while three cautious voices, spanning deep-value, GARP, and forensic frameworks, independently conclude the price already discounts perfection and offers a negative margin of safety. The panel lands at WAIT with high conviction, anchored by two clear triggers: a breakout above $540 or a pullback toward $400-442.Level to watch
Key resistance 496+2.6% from 483.36
Next catalyst
Breakout trigger: A weekly close above $540 negates the bearish MACD crossover, clears the volume supply zone between $496-540, and reasserts the monthly Stage 2 uptrend, flipping the panel to BUY.The panel's take
Verdict: WAIT · Conviction: HIGH · Last price: 483.36
What changed since 2026-08-01:
- Price: 476.15 → 483.36 (+1.51%)
- Panel: 1 of 6 → 2 of 6 now Bullish — composition also changed: added The Asymmetric Bargainer; removed The Quality Rationalist
- Trigger: BUY on a weekly close above $540 (negates the bearish MACD crossover, reclaims the volume supply zone, and reasserts the monthly Stage 2 uptrend) OR a pullback into the $400-442 zone (weekly EMA20 at $442, monthly Fib 38.2% at $382; entry below $442 with a stop at $382 offers favorable upside-versus-downside for a business whose trajectory is intact). SELL if weekly closes below $382 — breaks structural monthly support and signals Stage 2 is transitioning to Stage 3/4.
- Verdict: WAIT (unchanged)
The panel's verdict stays WAIT, but conviction rises from MEDIUM to HIGH. The prior panel had only one bullish voice, The Disruptive-Innovation Seeker. Adding The Scuttlebutt Growth Investor as a second bull strengthens the long-term business case, confirming AMD's qualitative compounder credentials. The Asymmetric Bargainer, replacing The Quality Rationalist, brings the Dhandho framework: an independent lens that corroborates the price objection without duplicating the Intrinsic-Value Modeler's DCF or the Forensic Skeptic's positioning read. The bearish weekly MACD crossover, new since the prior article, gives the WAIT a concrete technical anchor: $540 to invalidate, $442 to confirm. The net effect is that the business narrative keeps getting stronger while the price keeps getting harder to justify, and the panel now has three distinct, non-overlapping reasons to wait.
This is a textbook BUY-vs-WAIT split, not a BUY-vs-SELL split. Every cautious voice, even the two bears (The Intrinsic-Value Modeler, The Forensic Skeptic), frames the objection around price, not business quality. The Intrinsic-Value Modeler values AMD at $310 but says he'd buy below $350; The Forensic Skeptic says the business is good but the stock is a "terrible setup"; The GARP Operator says "great business at a bad price"; The Asymmetric Bargainer says "great company, questionable price." The technical scout explicitly recommends WAIT, identifying $442 and $540 as the actionable triggers. The only two pure BUY voices, The Scuttlebutt Growth Investor and The Disruptive-Innovation Seeker, argue from a 5-year horizon where today's price is noise, which implicitly concedes the short-term entry isn't optimal. The structure of the split is decisively BUY vs WAIT, and the WAIT side has a clear, specific trigger: a weekly close above $540 reasserts the bull trend, while a pullback to $400-442 creates a margin of safety. This isn't HOLD, because no one argues the valuation is fairly compensating for the risks: the bears explicitly say it isn't, and the bulls are making a multi-year conviction argument that doesn't need immediate entry.
Key levels
Key levels · AMD
USD · as of 2026-08-08Key support & resistance — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran Advanced Micro Devices past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Intrinsic-Value ModelerValuation/DCF🔴 BearishMed
Signal: AMD's current price of $483 requires a bull-case DCF where revenue grows at 40% for five years and operating margins reach 40%; my base case values the business at $310, implying 37% downside. Conviction: What tempers conviction is that the AI tailwind is genuine and Lisa Su's execution track record is excellent. The bull case isn't impossible, just fully priced with no room for error.
The GARP OperatorGrowth (GARP)⚫ NeutralMed
Signal: At a forward P/E of 50-60x with a PEG ratio near 2.5, AMD is a great business at a bad price: the stock fell 9% after beating and raising, signaling expectations have outrun reality. Conviction: A cluster of hard-to-dispute facts reinforces this: $9B net cash, operating cash flow exceeding net income, and 38% revenue growth. The only contested variable is whether the entry price is fair.
The Scuttlebutt Growth InvestorGrowth/Management🟢 BullishHigh
Signal: AMD passes 13 of 15 points on the growth-investing checklist this archetype uses, with Lisa Su's decade-long turnaround and the Meta 6-gigawatt GPU commitment confirming the qualitative hallmarks of a durable compounder. Conviction: Several independent signals point the same way: customer commitments, margin trajectory (+300bps YoY), and management depth. Only the software-moat gap and warrant dilution stand as manageable offsets.
The Disruptive-Innovation SeekerDisruptive Innovation🟢 BullishHigh
Signal: AI inference is in early adoption with a 5-year TAM of $1.5T, and AMD's chiplet architecture and the hyperscalers' strategic imperative to multi-source position it for 25-30% market share against NVIDIA's current 85% dominance. Conviction: Two structural forces independent of any single quarter's results bolster conviction here: Wright's Law cost declines favoring AMD's modular approach, and Meta's 6-GW commitment as a revealed-preference signal.
The Forensic SkepticContrarian/Forensic🔴 BearishMed
Signal: AMD beat Q2 estimates and raised guidance, yet the stock fell 9%: when the market sells your beat-and-raise, every marginal buyer has already bought, and 2.6% short interest confirms one-sided positioning. Conviction: Genuinely strong business fundamentals hold this back: OCF exceeding net income by 2x and a pristine balance sheet mean the bear case is purely about price and positioning, not decay, which makes timing the reversal harder.
The Asymmetric BargainerContrarian/Deep Value⚫ NeutralMed
Signal: This fails the 'heads I win, tails I don't lose much' test: a 40% probability of 30% downside versus a 25% probability of 50% upside produces an expected value that isn't Dhandho-worthy at $483. Conviction: The Meta warrant strengthens conviction: giving away nearly 10% of the company at a penny strike to secure demand independently signals AMD lacks the pricing power to justify its premium multiple.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- AI demand is real and accelerating, and AMD is the only credible #2 GPU supplier to NVIDIA.
- Lisa Su's execution is exceptional: the turnaround from near-bankruptcy to a data-center powerhouse is undisputed.
- The balance sheet is a fortress: $9B net cash, negligible debt, and operating cash flow that handily exceeds net income.
- ROCm lags CUDA, and closing that software gap is the single most important structural variable for AMD's long-term pricing power.
- The Meta deal validates real hyperscaler demand, but the warrant structure (up to 9.8% dilution at $0.01) raises legitimate questions about AMD's negotiating leverage.
- Valuation is stretched by any conventional metric: forward P/E of 50-60x, trailing P/E of 185x, and EV/EBITDA near 70x.
The real debate
- The Scuttlebutt Growth Investor and The Disruptive-Innovation Seeker both argue the current price is acceptable for a 5-year compounder where management quality and secular tailwinds overwhelm short-term valuation concerns, while The Intrinsic-Value Modeler, The Forensic Skeptic, and The Asymmetric Bargainer each independently conclude the price embeds perfection and offers a negative margin of safety.
- The Forensic Skeptic reads the Meta warrant as proof AMD lacks pricing power and had to bribe its way into hyperscaler demand; The Disruptive-Innovation Seeker reads the same warrant as proof of strategic indispensability, a customer locking in a long-term second source at any cost.
- The GARP Operator splits the difference: he wants to own AMD but not at this price, making him the swing vote that crystallizes the panel's WAIT. The business is a buy; the stock is not yet one.
The question it comes down to: Does AMD's AI growth trajectory justify paying for the bull case at today's price, or should investors wait for either a pullback that restores a margin of safety or a breakout above $540 that confirms the trend has resumed?
The bottom line
- Breakout trigger: A weekly close above $540 negates the bearish MACD crossover, clears the volume supply zone between $496-540, and reasserts the monthly Stage 2 uptrend, flipping the panel to BUY.
- Accumulation zone: A pullback into the $400–442 range (weekly EMA20 at $442, monthly Fib 38.2% near $382) would give the GARP Operator, Asymmetric Bargainer, and Intrinsic-Value Modeler the margin of safety they each independently require.
- Structural risk level: A weekly close below $382 breaks multi-month structural support and signals the monthly uptrend is transitioning to Stage 3/4, flipping the panel to SELL.
- Next catalyst: Q3 2026 earnings (guidance near $13B) represent the next test: a beat that again fails to lift the stock would confirm the Forensic Skeptic's 'no incremental buyer' thesis and raise the odds of a deeper correction.
- Further out: A ROCm adoption inflection: if a major cloud provider migrates 50%+ of inference workloads to AMD, the Intrinsic-Value Modeler's base-case DCF shifts upward and the entire valuation debate resets on more favorable terms.
contact@verdixhq.com · Published 2026-08-08 · Prices as of 2026-08-08 · Time horizon: 3–12 months · Founder holds a direct position in AMD · AMD verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s split verdict on AMD — and where they disagree.
The case for and against roughly balance — no clear edge at today's price.
NASDAQ · Information Technology · 2026-08-15 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
BalancedMEDIUM confidence
Why
AMD splits the panel down the middle: two voices see a compounding juggernaut with expanding margins and a data-center business doubling toward 2027, while two others see a stock at 18 times The Margin-of-Safety Hunter Number where 107% growth was partly bought with $82 billion in shareholder dilution. The remaining two are neutral, waiting for either a better price or macro clarity. The verdict lands at BALANCED — the business-quality dispute is genuine and neither side has a decisive edge at $514.Level to watch
Key support 496−3.6% from 514.39
Next catalyst
Trigger to confirm the breakout: A weekly close above $540 with volume expanding would signal the pullback is over and reaccumulation is complete, shifting the technical picture from neutral to outright bullish for The Macro Opportunist and The GARP Operator.The panel's take
Verdict: BALANCED · Conviction: MED · Last price: 514.39 · Changed from WAIT
What changed since 2026-08-08:
- Price: 483.36 → 514.39 (+6.42%)
- Panel: 2 of 6 → 2 of 6 now Bullish — composition also changed: added The Macro Opportunist, The Margin-of-Safety Hunter; removed The Asymmetric Bargainer, The Disruptive-Innovation Seeker
- Trigger: BUY trigger: weekly close above $540 with volume confirming the pullback is over AND any of (a) gross margins rising above 60%, (b) operating cash flow validating reported earnings, or (c) stock pulling back to $350-400. SELL trigger: weekly close below $480 breaking the reaccumulation zone, or a Q3 2026 guide-down / data-center deceleration below 80% YoY, or the OpenAI warrant dilution hitting the share count.
- Verdict: WAIT → BALANCED
The prior panel leaned WAIT with high conviction because two bullish voices (The GARP Operator and The Scuttlebutt Growth Investor) faced two skeptics and two neutrals, leaving no clear edge. This time, The Disruptive-Innovation Seeker and The Asymmetric Bargainer rotated off, replaced by The Macro Opportunist (neutral-leaning-bullish) and The Margin-of-Safety Hunter (emphatically bearish), which deepened the business-quality split rather than resolving it. The stock's 6.4% rally from $483 to $514 since early August did nothing to close the valuation gap — The Intrinsic-Value Modeler's DCF still points to ~$395 fair value, The Margin-of-Safety Hunter's The Margin-of-Safety Hunter Number is still $28, and The Forensic Skeptic's bear case of $300-$400 still looms. The deadlock holds because the business story got incrementally better (Q2 beat, raised guidance) but the price moved up with it, leaving the fundamental dispute exactly where it was.
The split is structurally BUY vs SELL: The Scuttlebutt Growth Investor and The GARP Operator are bullish on business quality, while The Forensic Skeptic and The Margin-of-Safety Hunter object on BUSINESS grounds (no moat, no margin of safety, the OpenAI warrant as purchased growth). The Macro Opportunist and The Intrinsic-Value Modeler are neutral — The Intrinsic-Value Modeler's DCF implies ~$395 fair value (a BUSINESS objection), The Macro Opportunist wants a better price (PRICE/TIMING objection). The business-level disagreement is genuine and deep: two voices see a 15/15 compounder, two see a speculative bubble at 123x earnings with hidden dilution. Neither side dominates, and the fundamental scout's 6.6/10 score with a BALANCED recommendation reinforces the deadlock. This routes to BALANCED per Step B — business-quality dispute, no decisive edge.
Key levels
Key levels · AMD
USD · as of 2026-08-15Key support & resistance — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran Advanced Micro Devices past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The GARP OperatorGrowth (GARP)🟢 BullishMed
Signal: Revenue up 50%, data center up 107%, EPS up 156%, and management is guiding for data center sales to double in 2027 — this is a company where every cloud provider and AI lab needs more of what it sells, and the balance sheet carries net cash with virtually no debt. Conviction: Conviction is held back because the trailing P/E over 120x means you are paying a premium for perfection, and the wild spread in PEG ratios — anywhere from 0.66 to 22 — tells me nobody really knows which growth number to trust.
The Intrinsic-Value ModelerValuation/DCF⚫ NeutralMed
Signal: My DCF, which bakes in 35% revenue growth for two years stepping down to 20%, a 30% steady-state operating margin, and the dilution from 160 million OpenAI warrant shares, spits out fair value around $395 per share — roughly 23% below the current price of $514. Conviction: Conviction is constrained because the bull case only gets me to $650, meaning even the rosiest scenario leaves modest upside, while the bear case at $240 is a 50% drawdown if growth compresses toward 25% and margins stall at 25%.
The Scuttlebutt Growth InvestorGrowth/Management🟢 BullishHigh
Signal: AMD passes all 15 points on the checklist — margins leapt from 40% to 54% in a single year, the CEO explicitly states demand is 'growing well above prior expectations,' and the data-center business delivered 107% year-over-year growth with a product pipeline (Instinct MI400, Helios, EPYC Turin) that extends visibility for years. Conviction: My conviction is buoyed by multiple independent signals: expanding gross margins, a fortress balance sheet, a deep management bench, and customer partnerships like the 6GW OpenAI deal that validate the product roadmap — no single assumption carries the thesis.
The Forensic SkepticContrarian/Forensic🔴 BearishMed
Signal: The OpenAI warrant — 160 million shares at a penny — means AMD handed one customer roughly $82 billion in shareholder value to secure demand, and when you strip away the growth headlines, the 107% data-center surge is partly purchased revenue, not organic competitive wins. Conviction: Skepticism hardens because the analyst consensus target of $533 implies only 3.6% upside from $514, yet 90% of analysts still say 'Buy,' the put/call ratio sits at 1.25, and no insider has stepped in to buy after a 10x run — the people hedging real money are telling a different story than the press releases.
The Macro OpportunistMacro/Timing⚫ NeutralMed
Signal: The monthly chart remains textbook Stage 2, the weekly pullback is digesting a run from $55 to $585 inside a volume cluster at $496–$540 that looks like reaccumulation, and management guided Q3 revenue to $13 billion, implying the business is accelerating, not rolling over. Conviction: Conviction stays medium because I lack macro clarity — if the Fed is draining liquidity, this stock gets crushed regardless of fundamentals — and the balance of upside to downside at $514 with a stop at $480 and a target at $650 gives only 1.3:1, which is not enough for a big swing.
The Margin-of-Safety HunterValue/Quantitative🔴 BearishHigh
Signal: The Margin-of-Safety Hunter Number comes to $28.22 per share, NCAV is $4.57 per share, and at $514 the stock trades at 18 times the Margin-of-Safety Hunter Number and 112 times net current asset value — a negative margin of safety so vast it would make a speculator blush. Conviction: The conviction behind a bearish stance is firm because the checklist fails on four of seven criteria: no dividend, a P/E of 123.6 against a required maximum of 15, a price-to-book near 25 against a required maximum of 1.5, and a P/E-times-P/B product around 3,090 against a ceiling of 22.5 — this is not a marginal miss, it is disqualification by an order of magnitude.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All six voices agree AMD's data-center business is delivering extraordinary revenue growth (+107% YoY) and the AI infrastructure buildout is a genuine secular demand wave, not a short-term blip.
- All six acknowledge the balance sheet is genuinely strong — net cash, minimal debt, current ratio above 2.5 — giving the company staying power through any cycle.
- All six recognize that valuation is the central tension: trailing multiples (P/E 123x, EV/EBITDA 82x, P/S 19x) are extreme by any historical standard, and the debate reduces to whether future earnings power justifies them.
- The panel converges on the OpenAI warrant as a material overhang, though they disagree sharply on whether it signals strategic positioning or hidden dilution.
The real debate
- The Scuttlebutt Growth Investor sees a 15/15 compounder where expanding margins, a deep management bench, and a multi-year product pipeline make today's price defensible on future earnings, while The Margin-of-Safety Hunter sees a stock trading at 18 times The Margin-of-Safety Hunter Number with no dividend and no conceivable margin of safety by any conservative measure.
- The GARP Operator frames the PEG ratio spread (0.66 to 22) as a warning that growth assumptions are too uncertain to anchor a position at 120x trailing earnings, whereas The Macro Opportunist frames the same uncertainty as a timing question — the theme is intact, the entry just needs to be better.
- The Forensic Skeptic reads the OpenAI warrant and the gap between AMD's 54% gross margin and NVIDIA's 70%+ as proof that AMD's moat is narrow and its growth is partly subsidized, while The Scuttlebutt Growth Investor reads the same warrant as evidence of customer-embedding depth that will compound over years.
The question it comes down to: Can AMD's data-center revenue growth and margin expansion compound fast enough over the next three years to grow into a valuation that, today, prices in nearly flawless execution — or will the first sign of deceleration expose a stock that has already run 10x on a narrative the options market no longer fully believes?
The bottom line
- Trigger to confirm the breakout: A weekly close above $540 with volume expanding would signal the pullback is over and reaccumulation is complete, shifting the technical picture from neutral to outright bullish for The Macro Opportunist and The GARP Operator.
- Risk to monitor: A weekly close below $480 breaks the reaccumulation zone and the 23.6% Fibonacci retracement, turning the weekly correction into a potential Stage 3 distribution pattern that would flip The Macro Opportunist bearish.
- Next catalyst: Q3 2026 earnings (guidance $13 billion) will test whether the beat-and-raise cycle has further to run; any deceleration in data-center growth below 80% year-over-year or a gross margin retreat below 50% would validate The Forensic Skeptic's thesis and likely trigger multiple compression.
- Valuation floor to watch: A pullback into the $350–$400 zone would bring the forward P/E into the low-to-mid 20s, meeting The Intrinsic-Value Modeler's and The Forensic Skeptic's threshold for a genuine margin of safety and aligning with The GARP Operator's preferred accumulation range.
- Further out: The mechanics of the OpenAI warrant exercise — when and how those 160 million shares hit the diluted count — will reveal whether the dilution is gradual and manageable or a one-time wealth transfer that resets EPS expectations sharply lower.
contact@verdixhq.com · Published 2026-08-15 · Prices as of 2026-08-15 · Time horizon: 3–12 months · Founder holds a direct position in AMD · AMD verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s case for AMD — and where they disagree.
The case for outweighs the case against at today's price.
NASDAQ · Information Technology · 2026-08-22 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
BuyLOW confidence
Why
AMD's post-selloff price of $473 splits the panel: three voices see a PEG of 0.65 on accelerating data-center growth as a rare bargain, while three others see a stock still priced for perfection with no cushion against Nvidia's CUDA moat or a semiconductor cycle turn. The debate hinges on whether revenue growth can run fast enough and long enough to absorb the 42x forward multiple before competitive pressures arrive.Level to watch
Key resistance 481.95+1.8% from 473.25
Next catalyst
Support level to watch: A weekly close below the 38.2% Fibonacci retracement at $418 would break the Stage 2 uptrend structure and likely flip the panel to a bearish posture.The panel's take
Verdict: BUY · Conviction: LOW · Last price: 473.25 · Changed from BALANCED
Panel: 3 Bullish · 3 Neutral · 0 Bearish → BUY
What changed since 2026-08-15:
- Price: 514.39 → 473.25 (-8.00%)
- Panel: 2 of 6 → 3 of 6 now Bullish — composition also changed: added The Disruptive-Innovation Seeker, The Moat Compounder; removed The Macro Opportunist, The Margin-of-Safety Hunter
- Trigger: A weekly close below the weekly 38.2% Fibonacci retracement at $418 would shift the technical picture from healthy Stage 2 correction to potential Stage 3 transition, breaking the structure that underpins the bull case. The technical scout, The GARP Operator, and The Forensic Skeptic all independently cite this level as the line where the bull thesis is seriously damaged — a close below it would likely flip the panel.
- Verdict: BALANCED → BUY
Three months ago, with the stock at $514 and a BALANCED verdict, the panel saw a growth story that was fully priced with no margin of safety. The subsequent 8% selloff to $473 changed the arithmetic for three of the six voices: the growth story strengthened (data-center revenue doubled, CEO guided 80% H2 server growth), while the price weakened just enough to shift The GARP Operator, The Disruptive-Innovation Seeker, and The Scuttlebutt Growth Investor into bullish territory. The two price-conscious holdouts acknowledge the stronger business but still see the valuation as stretched; they want a deeper pullback before committing.
The prior BALANCED's sell trigger at $480 fired — the stock broke below it, fell to $473, and that very selloff is what unlocked the BUY. Three of six voices now see the post-selloff price as an attractive entry into a growth story that has only strengthened (data-center revenue doubled, CEO guided 80% H2 server growth, PEG 0.65), while two holdouts do not dispute the business quality — they want a deeper pullback to $382–420 before committing — and a third stays neutral with a bearish tilt, flagging a 30x multiple on tangible book. Confidence is LOW because the weekly MACD bearish crossover is still in force and a retest of lower Fibonacci support is a live risk.
Key levels
Key levels · AMD
USD · as of 2026-08-22Analyst consensus target 613.09 USD · range 365–1,250
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key support at $459.61 (monthly Fibonacci 23.6% retracement from the $584.73 all-time high) is the first line of defense this pullback is testing — price rallied through it on 2026-07-20 before the current retreat. Below that, $418.37 (weekly 38.2% fib) marks the boundary between a healthy Stage 2 correction and a trend breakdown; it was last visited during the rally that launched from the March 2026 lows near $382. Key resistance at $481.95 (weekly 23.6% fib) is the bearish-invalidation line the technical scout flags — a weekly close above it signals the correction is over and the uptrend resumes toward the $584.73 all-time high. The analyst consensus target of $613.09 sits well above current resistance, implying the fundamental scouts' growth trajectory has room to run if the technical picture clears.
What legendary investors think
We ran Advanced Micro Devices past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue/Quality/Moat⚫ NeutralLow
Signal: At $473, the stock trades at <strong>42x forward earnings with an earnings yield below 1.1%, less than a risk-free 10-year Treasury at 4.7%</strong>, leaving no margin of safety for a business whose moat depends on closing a software ecosystem gap against Nvidia's entrenched CUDA platform. Conviction: Conviction stays low because the entire investment case rests on a single contested premise: that AMD's hardware specs alone can erode Nvidia's CUDA lock-in, and at this price the market has already priced that outcome as fact.
The GARP OperatorGrowth (GARP)🟢 BullishMed
Signal: The PEG ratio sits at <strong>0.65 on a 65% EPS CAGR, a rare sub-1.0 reading for a company whose data-center revenue just doubled year-over-year and whose CEO guided 80% server growth for the second half of 2026</strong>. Conviction: Conviction is reinforced by three independent pillars that do not rely on each other: the PEG under 1.0, a net-cash balance sheet with $5.41 per share in cash, and management's explicit multi-year growth guidance that any investor can verify against hyperscaler capex budgets.
The Intrinsic-Value ModelerValuation/DCF⚫ NeutralLow
Signal: The intrinsic value range comes out to <strong>$420 to $520, putting the current $473 price squarely inside the band with only 0.4% upside to the base case of $475</strong>, meaning the market is neither overpaying nor getting a discount on a business that must deliver 40% revenue growth for two years and expand operating margins from 15.8% to 30% just to hit fair value. Conviction: The estimate bands remain wide because two assumptions drive nearly all the value: the pace of margin expansion toward 30% and whether revenue growth can hold at 40% for two full years before decelerating, and neither has been independently confirmed by segment-level data.
The Disruptive-Innovation SeekerDisruptive Innovation🟢 BullishMed
Signal: AMD's data-center revenue more than doubled year-over-year with management guiding <strong>80% server growth in the second half of 2026, placing the company squarely in the accelerating early-adoption phase of the AI compute platform</strong>, well before the early majority arrives and validates the thesis. Conviction: What keeps conviction from being higher is the absence of a confirmed TAM figure for AI accelerators and the fact that Nvidia's CUDA ecosystem still controls roughly 80% of the market, creating a switching-cost barrier that even strong hardware execution may not fully overcome.
The Scuttlebutt Growth InvestorGrowth/Management🟢 BullishMed
Signal: The 15-point checklist scores <strong>13 out of 15, anchored by CEO Lisa Su's 12-year track record of transforming AMD from a distant second in CPUs into a credible contender in AI accelerators</strong>, with data-center revenue doubling and customer visibility described as much stronger than ever before. Conviction: Confidence is tempered by the two checklist items that remain unverified: labor relations and executive team depth beyond the CEO and CFO, because in a hypergrowth story, management bench strength determines whether the company can sustain innovation across multiple product cycles.
The Forensic SkepticContrarian/Forensic⚫ NeutralMed
Signal: Tangible book value sits at roughly <strong>$16 per share against a $473 stock price, a 30x multiple on hard assets, while the post-earnings selloff despite a headline beat confirms that whisper numbers ran so far ahead of the official print that even good news cannot satisfy the expectations embedded in the stock</strong>. Conviction: The bearish lean persists because the weekly MACD crossover is still in force, the monthly RSI remains overbought at 73.7, and every historical semiconductor cycle shows that stocks priced for perpetual hypergrowth typically give back gains faster than they accumulated them when the cycle turns.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All six agree the balance sheet is a fortress: $8.8B in net cash, debt-to-equity of 0.06, and operating cash flow exceeding net income by 1.6x.
- All six agree the data-center growth story is genuine: revenue doubled year-over-year, and hyperscaler demand visibility is strengthening.
- All six agree Nvidia's CUDA ecosystem represents the primary competitive risk, and AMD's ability to close that software gap is the variable that determines the long-term outcome.
- No voice disputes the quality of management under Lisa Su; the disagreement centers entirely on whether the current price already reflects that quality.
The real debate
- The GARP Operator sees a PEG of 0.65 as a clear undervaluation signal, while The Forensic Skeptic views the same 65% EPS CAGR as the very expectation that makes the stock fragile: a single guidance miss and the PEG collapses from 0.65 to well above 1.0 overnight.
- The Disruptive-Innovation Seeker treats the post-earnings 7% selloff as a sentiment-driven opportunity in an early-adoption story, whereas The Moat Compounder calculates an earnings yield below the risk-free rate and concludes the stock cannot be bought at any price above $400.
- The Scuttlebutt Growth Investor anchors conviction in management's explicit multi-year guidance and Lisa Su's execution record, while The Intrinsic-Value Modeler notes that even with management hitting its targets, the base-case intrinsic value barely exceeds the current price.
The question it comes down to: Can AMD's data-center revenue growth hold above 40% for long enough to compress the forward P/E from 42x into a growing earnings base before either Nvidia's CUDA moat or hyperscaler custom ASICs erode the growth rate?
The bottom line
- Support level to watch: A weekly close below the 38.2% Fibonacci retracement at $418 would break the Stage 2 uptrend structure and likely flip the panel to a bearish posture.
- Resistance to recapture: A weekly close above $482, the 23.6% Fibonacci retracement, would signal the correction has run its course and confirm the three bullish voices' timing thesis.
- Next catalyst: Q3 2026 earnings in late October: any miss on data-center revenue or guidance below the implied trajectory would directly undercut the 65% EPS CAGR that supports the current PEG ratio.
- Risk to monitor: A major hyperscaler announcement shifting GPU procurement toward internal ASICs or deeper Nvidia commitments would damage the thesis more than a routine quarterly miss, because it attacks the market-share assumption rather than the timing assumption.
contact@verdixhq.com · Published 2026-08-22 · Prices as of 2026-08-22 · Time horizon: 3–12 months · Founder holds a direct position in AMD · AMD verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel also debated